TY - JOUR
T1 - Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries
AU - Whelan, D. M.
AU - Van Der Giessen, W. J.
AU - Krabbendam, S. C.
AU - Van Vliet, E. A.
AU - Verdouw, P. D.
AU - Serruys, P. W.
AU - Van Beusekom, H. M.M.
PY - 2000
Y1 - 2000
N2 - Objective - To improve the biocompatibility of stents using a phosphorylcholine coated stent as a form of biomimicry. Interventions - Implantation of phosphorylcholine coated (n = 20) and non-coated (n = 21) stents was performed in the coronary arteries of 25 pigs. The animals were killed after five days (n = 6), four weeks (n = 7), and 12 weeks (n = 8), and the vessels harvested for histology, scanning electron microscopy, and morphometry. Main outcome measures - Stent performance was assessed by studying early endothelialisation, neointima formation, and vessel wall reaction to the synthetic coating. Results - Stent thrombosis did not occur in either group. Morphometry showed no significant differences between the two study groups at any time point. At five days both the coated and non- coated stents were equally well endothelialised (91% v 92%, respectively). At four and 12 weeks there was no difference in intimal thickness between the coated and non-coated stents. Up to 12 weeks postimplant the phosphorylcholine coating was still discernible in the stent strut voids, and did not appear to elicit an adverse inflammatory response. Conclusion - In this animal model the phosphorylcholine coating showed excellent blood and tissue compatibility, unlike a number of other polymers tested in a similar setting. Given that the coating was present up to 12 weeks postimplant with no adverse tissue reaction, it may be a potential candidate polymer for local drug delivery.
AB - Objective - To improve the biocompatibility of stents using a phosphorylcholine coated stent as a form of biomimicry. Interventions - Implantation of phosphorylcholine coated (n = 20) and non-coated (n = 21) stents was performed in the coronary arteries of 25 pigs. The animals were killed after five days (n = 6), four weeks (n = 7), and 12 weeks (n = 8), and the vessels harvested for histology, scanning electron microscopy, and morphometry. Main outcome measures - Stent performance was assessed by studying early endothelialisation, neointima formation, and vessel wall reaction to the synthetic coating. Results - Stent thrombosis did not occur in either group. Morphometry showed no significant differences between the two study groups at any time point. At five days both the coated and non- coated stents were equally well endothelialised (91% v 92%, respectively). At four and 12 weeks there was no difference in intimal thickness between the coated and non-coated stents. Up to 12 weeks postimplant the phosphorylcholine coating was still discernible in the stent strut voids, and did not appear to elicit an adverse inflammatory response. Conclusion - In this animal model the phosphorylcholine coating showed excellent blood and tissue compatibility, unlike a number of other polymers tested in a similar setting. Given that the coating was present up to 12 weeks postimplant with no adverse tissue reaction, it may be a potential candidate polymer for local drug delivery.
KW - Biocompatible materials
KW - Coatings
KW - Phosphorylcholine
KW - Stents
UR - http://www.scopus.com/inward/record.url?scp=0034022046&partnerID=8YFLogxK
U2 - 10.1136/heart.83.3.338
DO - 10.1136/heart.83.3.338
M3 - Article
C2 - 10677417
AN - SCOPUS:0034022046
SN - 1355-6037
VL - 83
SP - 338
EP - 345
JO - Heart
JF - Heart
IS - 3
ER -